0 participants
A Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-03-17
- Start Date:
- 2015-12-31
- Completion:
- 2016-11-30
Conditions
- Indolent Non-Hodgkin's Lymphoma
- Follicular Lymphoma
- Small Lymphocytic Lymphoma
- Marginal Zone Lymphoma
Interventions
- DRUG
No Results Yet